How Long Can You Stay Off Eliquis with AFib?
You should not intentionally stop Eliquis (apixaban) for atrial fibrillation unless there is a specific medical reason, and any interruption must be carefully managed based on the clinical context—the half-life of apixaban is approximately 12 hours, meaning anticoagulant effect substantially diminishes within 24-48 hours, rapidly increasing stroke risk. 1
Understanding Apixaban Pharmacokinetics
The critical window for stroke risk begins immediately after discontinuation:
- Apixaban has a half-life of approximately 12 hours, meaning therapeutic anticoagulation wanes within 1-2 days of the last dose 1
- Renal elimination accounts for 27% of clearance, with the remainder metabolized hepatically via CYP3A4 1
- After stopping apixaban, anticoagulant protection is essentially lost within 24-48 hours (approximately 2-4 half-lives) 1
Planned Interruption for Surgery or Procedures
Low Bleeding Risk Procedures
For procedures with minor bleeding risk (dental extractions, cataract surgery, superficial dermatologic procedures):
- Stop apixaban 24 hours before the procedure (last dose 24 hours pre-op) 2
- Resume apixaban 6-8 hours after the procedure once hemostasis is secure 2
- No bridging anticoagulation is required for this brief interruption 2
High Bleeding Risk Procedures
For procedures with high bleeding risk (major orthopedic surgery, thoracic/abdominal surgery, spinal anesthesia):
- Stop apixaban 48 hours before the procedure if creatinine clearance >50 mL/min 2
- Stop apixaban 72 hours before the procedure if creatinine clearance 30-50 mL/min 2
- Resume apixaban 48-72 hours after the procedure when bleeding risk has stabilized 2
- Consider prophylactic-dose LMWH starting 6-8 hours post-operatively until full-dose apixaban is resumed 2
Common pitfall: Do not use reduced-dose apixaban (such as VTE prophylaxis doses) in the post-operative period for AF patients—either use prophylactic LMWH or resume full therapeutic apixaban dosing 2
Unplanned Interruption: Stroke Risk Timeline
If apixaban is unintentionally stopped or a patient misses doses:
- Within 12-24 hours: Anticoagulant effect begins declining but some protection remains 1
- 24-48 hours: Anticoagulant protection is substantially lost; stroke risk returns to baseline unprotected levels 1
- Beyond 48 hours: Patient is essentially unprotected, with stroke risk determined by CHA₂DS₂-VASc score 3
The highest stroke risk occurs within the first 72 hours to 10 days after stopping anticoagulation, particularly in the peri-cardioversion setting, but this principle applies to any interruption 3
Cardioversion-Specific Interruption Rules
If cardioversion is planned and apixaban must be interrupted:
- For AF >48 hours or unknown duration: Apixaban must be continued for at least 3 weeks before and at least 4 weeks after cardioversion 3
- Brief interruption for the procedure itself (electrical cardioversion) is acceptable, with resumption immediately after 3
- The 4-week post-cardioversion requirement is mandatory regardless of whether sinus rhythm is maintained, due to atrial stunning 3, 4
What NOT to Do
- Never stop apixaban abruptly without a plan for resumption or bridging, as this creates an unprotected window for thromboembolism 3
- Never assume that maintaining sinus rhythm after cardioversion eliminates the need for anticoagulation—long-term decisions are based on CHA₂DS₂-VASc score, not rhythm 3
- Never use heparin or LMWH as "bridging" in the first 48 hours after acute ischemic stroke, as this increases hemorrhagic transformation risk without benefit 5
Restarting After Interruption
- For elective procedures: Resume apixaban at the standard AF dose (5 mg twice daily, or 2.5 mg twice daily if dose-reduction criteria are met) as soon as adequate hemostasis is achieved 2
- After acute ischemic stroke: Timing depends on stroke severity—mild strokes may allow restart at 3-6 days, severe strokes require waiting 12-14 days 6
- Rivaroxaban must be taken with food for proper absorption in the AF indication; apixaban does not have this requirement 2
Maximum Safe Duration Off Apixaban
There is no "safe" maximum duration to remain off apixaban for a patient with AF requiring anticoagulation—every day without anticoagulation increases cumulative stroke risk proportional to the patient's CHA₂DS₂-VASc score 3. For a patient with CHA₂DS₂-VASc ≥2 (men) or ≥3 (women), the annual stroke risk without anticoagulation ranges from 2.2% to >9%, translating to a daily risk of 0.006% to 0.025% 7. The only acceptable interruptions are those mandated by bleeding risk from procedures, with resumption as soon as medically feasible 2.